HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Szekeres Selected Research

3,3',4,4',5,5'-hexahydroxystilbene

6/20103,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
8/2008Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase.
10/2006Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
9/2006Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Szekeres Research Topics

Disease

39Neoplasms (Cancer)
10/2017 - 04/2002
21Leukemia
10/2017 - 04/2002
14Breast Neoplasms (Breast Cancer)
08/2015 - 07/2005
4Pancreatic Neoplasms (Pancreatic Cancer)
10/2013 - 02/2008
4Colonic Neoplasms (Colon Cancer)
02/2009 - 04/2002
3Liver Diseases (Liver Disease)
12/2021 - 01/2021
3Inflammation (Inflammations)
12/2021 - 01/2011
3Heart Failure
10/2021 - 10/2007
3Melanoma (Melanoma, Malignant)
03/2015 - 06/2010
3Neoplasm Metastasis (Metastasis)
03/2015 - 07/2013
3Carcinoma (Carcinomatosis)
11/2012 - 07/2005
2Stroke (Strokes)
10/2021 - 01/2019
2Pulmonary Embolism
10/2021 - 10/2007
2Portal Hypertension
10/2021 - 01/2021
2Heart Diseases (Heart Disease)
10/2021 - 06/2010
2Myocardial Infarction
01/2019 - 10/2007
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2015 - 01/2015
2Coronary Disease (Coronary Heart Disease)
06/2012 - 01/2008
2Lymphoma (Lymphomas)
03/2009 - 07/2005
2Glioma (Gliomas)
10/2004 - 04/2002
2Leukemia L1210
08/2004 - 04/2002
1COVID-19
12/2021
1Fibrosis (Cirrhosis)
12/2021
1Wounds and Injuries (Trauma)
10/2021
1Kidney Diseases (Kidney Disease)
10/2021
1Thrombosis (Thrombus)
10/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Brain Ischemia (Cerebral Ischemia)
01/2020
1Insulin Resistance
01/2020
1Pediatric Obesity
01/2020
1Out-of-Hospital Cardiac Arrest
01/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019

Drug/Important Bio-Agent (IBA)

19ResveratrolIBA
03/2015 - 03/2005
15Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2017 - 08/2002
14Cytarabine (Cytosar-U)FDA LinkGeneric
10/2017 - 08/2002
7DNA (Deoxyribonucleic Acid)IBA
01/2018 - 03/2005
7Pharmaceutical PreparationsIBA
10/2017 - 04/2002
6Hormones (Hormone)IBA
10/2021 - 09/2007
6EnzymesIBA
10/2013 - 04/2002
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2011 - 01/2007
4StilbenesIBA
06/2010 - 10/2006
43,3',4,4',5,5'-hexahydroxystilbeneIBA
06/2010 - 09/2006
4Floxuridine (FUdR)FDA LinkGeneric
07/2005 - 09/2003
3Gallic AcidIBA
01/2018 - 01/2007
3Antineoplastic Agents (Antineoplastics)IBA
10/2017 - 04/2002
3Proteins (Proteins, Gene)FDA Link
08/2015 - 10/2009
3digalloylresveratrolIBA
10/2013 - 02/2009
3Phosphates (Orthophosphate)IBA
06/2012 - 08/2004
33,3',4,5'-tetrahydroxystilbeneIBA
12/2010 - 09/2006
3AvemarIBA
03/2009 - 02/2005
3AntioxidantsIBA
08/2008 - 09/2006
2C-Reactive ProteinIBA
12/2021 - 01/2020
2ReninIBA
12/2021 - 10/2021
2AldosteroneIBA
12/2021 - 10/2021
2Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2020
2Brain Natriuretic Peptide (Natrecor)FDA Link
10/2021 - 10/2007
2Natriuretic PeptidesIBA
10/2021 - 10/2007
2pro-brain natriuretic peptide (1-76)IBA
10/2021 - 01/2009
2Anaplastic Lymphoma KinaseIBA
08/2015 - 01/2015
2Messenger RNA (mRNA)IBA
08/2015 - 03/2010
2PolyphenolsIBA
01/2015 - 10/2009
2triphosphoric acid (triphosphate)IBA
01/2015 - 12/2010
2Sulfates (Sulfates, Inorganic)IBA
09/2014 - 03/2010
2GemcitabineFDA Link
11/2012 - 02/2008
2Estrogens (Estrogen)FDA Link
09/2012 - 12/2010
2Biological ProductsIBA
06/2011 - 09/2007
2SulfotransferasesIBA
03/2010 - 03/2008
2CytidineIBA
02/2009 - 03/2005
2Fluorouracil (Carac)FDA LinkGeneric
02/2009 - 08/2004
23'-C-methyladenosineIBA
07/2008 - 07/2005
2Deuterium Oxide (Heavy Water)IBA
02/2008 - 09/2005
23,4,5-trihydroxybenzamidoximeIBA
02/2006 - 08/2002
2tiazofurinIBA
03/2005 - 04/2002
2Carmustine (FIVB)FDA Link
10/2004 - 08/2004
23,4-dihydroxybenzohydroxamic acidIBA
10/2004 - 08/2004
23-(1-deoxyribofuranosyl)benzamideIBA
04/2002 - 04/2002
1PlasminogenIBA
12/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2021
1Prothrombin (Factor II)IBA
12/2021
1AntigensIBA
12/2021
1fibrin fragment D (D-dimer)IBA
12/2021
1Antifibrinolytic Agents (Antifibrinolytics)IBA
12/2021
1Interleukin-6 (Interleukin 6)IBA
12/2021
1von Willebrand FactorIBA
12/2021
1Arginine Vasopressin (Argipressin)IBA
10/2021
1AngiotensinsIBA
10/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1LeptinIBA
01/2020
1AdipokinesIBA
01/2020
1AdiponectinIBA
01/2020
1omega-Chloroacetophenone (Mace)IBA
01/2019
1Phospholipases (Phospholipase)IBA
01/2019
1TroponinIBA
01/2019

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2011 - 04/2002
6Therapeutics
03/2014 - 04/2002
2Combination Drug Therapy (Combination Chemotherapy)
03/2005 - 10/2004
1Transjugular Intrahepatic Portasystemic Shunt
01/2021
1Liver Transplantation
01/2021
1Art Therapy
01/2019